Escabarte, Gregorio .
HRN: 26-31-91 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/04/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/04/2024
12/17/2024
IVT
4.5g
Q8
Scapular Mass Left, Malignancy Vs Infection
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes